131 related articles for article (PubMed ID: 34279604)
1. A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation.
Noubiap JJ; Feteh VF; Middeldorp ME; Fitzgerald JL; Thomas G; Kleinig T; Lau DH; Sanders P
Europace; 2021 Oct; 23(10):1528-1538. PubMed ID: 34279604
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
3. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.
Bassand JP; Virdone S; Goldhaber SZ; Camm AJ; Fitzmaurice DA; Fox KAA; Goto S; Haas S; Hacke W; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK
Circulation; 2019 Feb; 139(6):787-798. PubMed ID: 30586740
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF.
Ambrosio G; Camm AJ; Bassand JP; Corbalan R; Kayani G; Carluccio E; Mantovani LG; Virdone S; Kakkar AK;
ESC Heart Fail; 2021 Apr; 8(2):1139-1149. PubMed ID: 33434417
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
7. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis.
Grymonprez M; Steurbaut S; De Sutter A; Lahousse L
Open Heart; 2020 Dec; 7(2):. PubMed ID: 33361315
[TBL] [Abstract][Full Text] [Related]
8. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
[TBL] [Abstract][Full Text] [Related]
9. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.
Takabayashi K; Hamatani Y; Yamashita Y; Takagi D; Unoki T; Ishii M; Iguchi M; Masunaga N; Ogawa H; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GY; Akao M
Stroke; 2015 Dec; 46(12):3354-61. PubMed ID: 26514188
[TBL] [Abstract][Full Text] [Related]
13. Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
Hacke W; Bassand JP; Virdone S; Camm AJ; Fitzmaurice DA; Fox KA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AG; van Eickels M; Verheugt FW; Kakkar AK;
Int J Stroke; 2020 Apr; 15(3):308-317. PubMed ID: 31847794
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
[TBL] [Abstract][Full Text] [Related]
15. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
[TBL] [Abstract][Full Text] [Related]
16. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
[TBL] [Abstract][Full Text] [Related]
17. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
18. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
Hsu JC; Huang YT; Lin LY
Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry.
Yamashita Y; Hamatani Y; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
Chest; 2016 Feb; 149(2):401-412. PubMed ID: 26181726
[TBL] [Abstract][Full Text] [Related]
20. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
